These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38233227)

  • 1. Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents.
    Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):260-267. PubMed ID: 38233227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patents.
    Singh VK; Garcia M; Wise SY; Seed TM
    Expert Opin Ther Pat; 2016 Dec; 26(12):1431-1447. PubMed ID: 27599259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Strategic National Stockpile: identification, support, and acquisition of medical countermeasures for CBRN incidents.
    Neumeister SM; Gray JP
    Toxicol Mech Methods; 2021 May; 31(4):308-321. PubMed ID: 33208007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public Health Responses to CBRN Terrorism in the Middle East and North Africa.
    Mani Z; Plummer V; Kuhn L; Khorram-Manesh A; Tin D; Goniewicz K
    Disaster Med Public Health Prep; 2024 Apr; 18():e87. PubMed ID: 38618924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interdependent Factors of Demand-Side Rationale for Chemical, Biological, Radiological, and Nuclear Medical Countermeasures.
    Johnson ML; Belin J; Dorandeu F; Guille M
    Disaster Med Public Health Prep; 2020 Dec; 14(6):739-755. PubMed ID: 31735188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.
    Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):273-300. PubMed ID: 37977814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents.
    Singh VK; Romaine PL; Newman VL; Seed TM
    Expert Opin Ther Pat; 2016 Dec; 26(12):1399-1408. PubMed ID: 27610458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in medical device triage technologies for chemical, biological, radiological, and nuclear events.
    Lansdowne K; Scully CG; Galeotti L; Schwartz S; Marcozzi D; Strauss DG
    Prehosp Disaster Med; 2015 Jun; 30(3):320-3. PubMed ID: 25868677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology of organophosphorus compounds in view of an increasing terrorist threat.
    Worek F; Wille T; Koller M; Thiermann H
    Arch Toxicol; 2016 Sep; 90(9):2131-2145. PubMed ID: 27349770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Office of the Assistant Secretary for Preparedness and Response; HHS Public Health Emergency Medical Countermeasures Enterprise implementation plan for chemical, biological, radiological and nuclear threats. Notice.
    Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services
    Fed Regist; 2007 Apr; 72(77):20117-28. PubMed ID: 17520758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Descriptive Analysis of the Use of Chemical, Biological, Radiological, and Nuclear Weapons by Violent Non-State Actors and the Modern-Day Environment of Threat.
    Tin D; Cheng L; Shin H; Hata R; Granholm F; Braitberg G; Ciottone G
    Prehosp Disaster Med; 2023 Jun; 38(3):395-400. PubMed ID: 37185132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institutes of Health (NIH) Executive Meeting Summary: Developing Medical Countermeasures to Rescue Opioid-Induced Respiratory Depression (a Trans-Agency Scientific Meeting)-August 6/7, 2019.
    Yeung DT; Bough KJ; Harper JR; Platoff GE
    J Med Toxicol; 2020 Jan; 16(1):87-105. PubMed ID: 31853736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terrorism-Related Chemical, Biological, Radiation, and Nuclear Attacks: A Historical Global Comparison Influencing the Emergence of Counter-Terrorism Medicine.
    Tin D; Granholm F; Hart A; Ciottone GR
    Prehosp Disaster Med; 2021 Aug; 36(4):399-402. PubMed ID: 34190037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A psychosocial risk assessment and management framework to enhance response to CBRN terrorism threats and attacks.
    Lemyre L; Clément M; Corneil W; Craig L; Boutette P; Tyshenko M; Karyakina N; Clarke R; Krewski D;
    Biosecur Bioterror; 2005; 3(4):316-30. PubMed ID: 16366841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of drug-approval regulations for medical countermeasures against CBRN agents in Japan.
    Shimazawa R; Ikeda M
    Health Secur; 2015; 13(2):130-8. PubMed ID: 25813978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celebrating 60 Years of Accomplishments of the Armed Forces Radiobiology Research Institute1.
    Bene BJ; Blakely WF; Burmeister DM; Cary L; Chhetri SJ; Davis CM; Ghosh SP; Holmes-Hampton GP; Iordanskiy S; Kalinich JF; Kiang JG; Kumar VP; Lowy RJ; Miller A; Naeem M; Schauer DA; Senchak L; Singh VK; Stewart AJ; Velazquez EM; Xiao M
    Radiat Res; 2021 Aug; 196(2):129-146. PubMed ID: 33979439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting discovery and development of medical countermeasures for chemical injury to eye and skin.
    Araj H; Tseng H; Yeung DT
    Exp Eye Res; 2022 Aug; 221():109156. PubMed ID: 35716762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency Response to Radiological Releases: Have We Communicated Effectively to the First Responder Communities to Prepare Them to Safely Manage These Incidents?
    Ingram RJ
    Health Phys; 2018 Feb; 114(2):208-213. PubMed ID: 30086017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Agent Use in Terrorist Events: A Gathering Storm Requiring Enhanced Civilian Preparedness.
    Tin D; Ciottone GR
    Prehosp Disaster Med; 2022 Jun; 37(3):327-332. PubMed ID: 35392992
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.